FCM MM Holdings, one of Mind Medicine’s (NEO: MMED) shareholders with a 6.1% stake, has formally filed a complaint with The post Activist Investor Calls...
Clairvoyant Therapeutics, a clinical stage biotech company focused on the development of psychedelic drug therapies for the treatment of addiction, is...
Leaders– our world wouldn’t run without them. They present themselves in many forms. They are our bosses, our government officials, our parents, our...
The article Small Pharma Receives Approval for Phase I DMT Clinical Trial was originally published on Microdose. For more on Small Pharma check out Small...
Executive Spotlight: Marco Algorta Beramendi Title: CEO Company: Bienstar Wellness Years at current company: 1 Education profile: Marco is a storytelling...
The article Microdose Announces Sponsors For Wonderland 2022 was originally published on Microdose. The leader in the business of psychedelics, Microdose...
11th annual conference will feature prominent speakers and artists including Dennis McKenna, Vanessa Le-Fan Yuen and Paul Stamets joining virtually from...
The article Numinus Launches Ketamine Program for Chronic and Serious Illness was originally published on Microdose. Numinus Launches Psychedelic-Assisted...
Robert Huizinga → According to an SEC filing, Aurinia’s EVP of research Robert Huizinga and CMO Neil Solomons are both walking away by Halloween, and...
The founder of two leading psychedelic science companies and an influential nonprofit is shaping research, as well as efforts to patent it. The post...